Search

Search Constraints

You searched for: Author/Creator Bayman, Neil

Search Results

1. A UK centre's experience of stereotactic ablative radiotherapy (SABR) for very early-stage small-cell lung cancer (SCLC). (April 2023)

2. An evaluation of concurrent chemoradiotherapy practice for locally advanced non-small cell lung cancer (NSCLC) in a single centre institution. (March 2022)

3. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Issue 10055 (22nd October 2016)

4. Early evaluation of a new regional pathway for tri-modality treatment in stage III-N2 NSCLC in Greater Manchester. (March 2022)

5. Impact of introducing intensity modulated radiotherapy (IMRT) on curative intent radiotherapy and survival for lung cancer. (March 2022)

6. Implementing a sustainable lung SABR planning pathway: reducing inefficiencies and improving timeliness of treatment. (April 2023)

7. Initial findings following the routine implementation of electronic patient reported outcome measures (ePROMs) for patients with lung cancer at the Christie NHS Foundation Trust. (March 2022)

8. Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?. (April 2018)

9. Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). (July 2021)

10. Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study. Issue 4 (15th April 2016)